1[1]Weaver F,Follett K,Hur K,et al.Deep brain stimulation in Parkinson disease:a metaanalysis of patient outcomes.J Neurosurg,2005,103(6):956-967.
2[2]Haas BM,Trew M,Castle PC.Effects of respiratory muscle weakness on daily living function,quality of life,activity levels,and exercise capacity in mild to moderate Parkinson's disease.Am J Phys Med Rehabil,2004,83:601-607.
3[3]Furuya R,Hirai A,Andoh T,et al.Successful perioperative management of a patient with Parkinson's disease by enteral Levodopa administration under propofol anesthesia.Anesthesiology,1998,89:261-263.
4[5]Reed AP,Han DG.Intraoperative exacerbation of Parkinson's disease.Anesth Analg,1992,75:850-853.
5[6]Golden WE,Lavender RC,Metzer WS.Acute postoperative confusion and hallucinations in Parkinson disease.Ann Intern Med,1989,111:218-222.
6[7]Fischer SP,Mantin R,Brock-Utne JG.Ketorolac and propofol anesthesia in a patient taking chronic monamine oxidase inhibitors.J Clin Anesth,1996,8:245-247.
7[8]Mantz J,Varlet C,Lecharny J-B,et al.Effects of volatile anesthetics,thiopental,and ketamine on spontaneous and depolarization-evoked dopamine release from striatal synaptosomes in the rat.Anesthesiology,1994,80:352-363.
8[9]Krauss JK,Akeyson EW,Giam P,et al.Propofol-inducesd dyskinesias in Parkison's disease.Anesth Analg,1996,83:420-422.
9[10]Anderson BJ,Marks PV,Futter ME.Propofol:contrasting effects in movement disorders.Br J Neurosurg,1994,8:387-388.
10[11]V.Fodale,C.Praticò,L.B.Drugs of anesthesia,central nicotinic receptors and Parkinson's disease.Parkinsonism and Related Disorders,2004,10:189-190.
8Chan KC, Gill GS. Cemented hemiarthroplasties for elderly patients with intertrochanteric fractures [ J ]. Clin Orthop, 2000,371 : 206 - 215.
9Schwalb JM, Hamani C. The history and future of deep brain stimulation. Neurotherapeutics, 2008, 5:3-13.
10Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery, 2005, 56:722-732.
